We are live on
!
Find out more
EA
Emerald Advisers Portfolio holdings
AUM
$3.16B
1-Year Est. Return
109.58%
This Fund
S&P 500
This Quarter
Est. Return
+7.49%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$1.78B
AUM Growth
-$68.3M
(-3.7%)
Cap. Flow
-$132M
Cap. Flow
% of AUM
-7.44%
Top 10 Holdings %
Top 10 Hldgs %
16.28%
Holding
390
New
41
Increased
102
Reduced
174
Closed
34
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$9.23M |
| 2 |
ASRT
Assertio
ASRT
|
+$8.76M |
| 3 |
ITMN
INTERMUNE INC
ITMN
|
+$8.58M |
| 4 |
EPZM
Epizyme, Inc
EPZM
|
+$8.51M |
| 5 |
Kforce
KFRC
|
+$8.18M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
+$40.2M |
| 2 |
AKRX
Akorn Inc
AKRX
|
+$21.7M |
| 3 |
BCOV
Brightcove, Inc.
BCOV
|
+$10.6M |
| 4 |
REXX
Rex Energy Corporation
REXX
|
+$8.91M |
| 5 |
Meritage Homes
MTH
|
+$8.41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 17.87% |
| 2 | Technology | 15.37% |
| 3 | Healthcare | 14.23% |
| 4 | Financials | 11.54% |
| 5 | Consumer Discretionary | 10.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
General Motors
GM
$68.3B
| $367K | 0.02% |
+10,657
| New | +$391K |
|
302
3M
MMM
$83B
| $364K | 0.02% |
3,205
-394
| -11% | -$43.8K |
|
303
United Parcel Service
UPS
$96.2B
| $362K | 0.02% |
+3,713
| New | +$362K |
|
304
Boeing
BA
$165B
| $337K | 0.02% |
2,689
-116
| -4% | -$15.1K |
|
305
Eli Lilly
LLY
$1.02T
| $337K | 0.02% |
5,729
-1,433
| -20% | -$80K |
|
306
Arbutus Biopharma
ABUS
$871M
| $328K | 0.02% |
15,250
+50
| +0.3% | +$898 |
|
307
PNC Financial Services
PNC
$99.8B
| $317K | 0.02% |
3,640
-289
| -7% | -$23.6K |
|
308
Phillips 66
PSX
$83.7B
| $313K | 0.02% |
4,062
-671
| -14% | -$51.1K |
|
|
LPDX
309
DELISTED
LIPOSCIENCE INC COM
LPDX
| $312K | 0.02% |
97,750
-300,566
| -75% | -$1.26M |
|
310
Deere & Co
DE
$158B
| $305K | 0.02% |
+3,363
| New | +$294K |
|
311
Merck
MRK
$307B
| $296K | 0.02% |
5,467
-1,585
| -22% | -$82.1K |
|
312
Caterpillar
CAT
$398B
| $292K | 0.02% |
2,939
-347
| -11% | -$32.7K |
|
313
AbbVie
ABBV
$448B
| $291K | 0.02% |
5,665
-1,314
| -19% | -$66.4K |
|
314
Honeywell
HON
$71.7B
| $288K | 0.02% |
3,456
+241
| +7% | +$19.9K |
|
|
MRO
315
DELISTED
Marathon Oil Corporation
MRO
| $287K | 0.02% |
8,066
-1,715
| -18% | -$57.8K |
|
316
Amgen
AMGN
$197B
| $286K | 0.02% |
2,322
-410
| -15% | -$49.7K |
|
|
TWX
317
DELISTED
Time Warner Inc
TWX
| $275K | 0.02% |
4,385
-807
| -16% | -$50.7K |
|
318
Freeport-McMoran
FCX
$84.5B
| $274K | 0.02% |
8,273
-129
| -2% | -$4.29K |
|
319
Travelers Companies
TRV
$78.4B
| $270K | 0.02% |
3,173
+531
| +20% | +$44.6K |
|
320
Altria Group
MO
$125B
| $264K | 0.01% |
7,046
-5,839
| -45% | -$212K |
|
321
Aflac
AFL
$63.2B
| $246K | 0.01% |
7,802
-554
| -7% | -$17.6K |
|
|
HES
322
DELISTED
Hess
HES
| $245K | 0.01% |
2,956
-739
| -20% | -$58.7K |
|
323
Medtronic
MDT
$107B
| $242K | 0.01% |
3,935
-876
| -18% | -$51K |
|
|
ICAD
324
DELISTED
iCAD Inc
ICAD
| $237K | 0.01% |
+25,910
| New | +$296K |
|
|
WBA
325
DELISTED
Walgreens Boots Alliance
WBA
| $237K | 0.01% |
3,583
-285
| -7% | -$17.9K |
|
Similar funds
AWE
FTUS
BFA
BP
CVA
DWP
GKWIM
BI
Emerald Advisers's Q1 2014 Portfolio in Review
As of Q1 2014, Emerald Advisers held 390 positions worth $1.78B, down 3.7% from $1.85B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Emerald Advisers withdrew a net $132M in Q1 2014, closing 34 positions and reducing 174 holdings. Its most notable exit was Akorn Inc, an estimated $21.7M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 18% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Emerald Advisers opened a new position in Horizon Therapeutics Public Limited Company Ordinary Shares worth $12.4M.
- Emerald Advisers's largest Q1 2014 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 817,410 shares worth $12.4M.
- Emerald Advisers added most to PacWest Bancorp in Q1 2014, an estimated $7.25M increase.
- Emerald Advisers's biggest Q1 2014 reduction was Intercept Pharmaceuticals, Inc., cutting an estimated $40.2M.
- Emerald Advisers fully exited Akorn Inc in Q1 2014, selling an estimated $21.7M.
- Emerald Advisers's ten largest holdings make up 16% of its $1.78B portfolio in Q1 2014.
- Emerald Advisers opened 41 new positions and closed 34 in Q1 2014.
- Emerald Advisers's portfolio value fell 3.7% quarter-over-quarter to $1.78B.
Based on Emerald Advisers's 13F filing for Q1 2014, filed 30 Apr 2014.